Literature DB >> 12804609

Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor.

Tetsuya Yamamoto1, Noriko Sato, Yuichi Sekine, Taro Yumioka, Seiyu Imoto, Akira Junicho, Hideki Fuse, Tadashi Matsuda.   

Abstract

STAT3 mainly acts as a signal transducer of IL-6 family cytokines and transcriptionally activates specific target genes. The recently discovered protein inhibitor of activated STAT3 (PIAS3) binds directly to STAT3 and blocks transcriptional activation. In our previous report, we demonstrated that PIAS3 directly interacted with androgen receptor (AR) and affected AR-mediated gene activation. Furthermore, we also showed that AR associated with STAT3 and enhanced its activity. Here, we examined molecular interactions between STAT3, PIAS3, and AR to underline the mechanism of how they regulate each other. AR activation overcame the inhibitory effect on STAT3-mediated transcription by PIAS3. Co-immunoprecipitation experiments revealed that an active form of AR relieved STAT3 from STAT3-PIAS3 complex formation. These results indicate that AR and PIAS3 regulate the STAT3-mediated transcriptional activity by their physical protein-protein competition on STAT3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12804609     DOI: 10.1016/s0006-291x(03)01026-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  The Nuclear Translocation of Heme Oxygenase-1 in Human Diseases.

Authors:  Qing Yang; Wenqian Wang
Journal:  Front Cell Dev Biol       Date:  2022-06-29

2.  Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.

Authors:  Belen Elguero; Geraldine Gueron; Jimena Giudice; Martin A Toscani; Paola De Luca; Florencia Zalazar; Federico Coluccio-Leskow; Roberto Meiss; Nora Navone; Adriana De Siervi; Elba Vazquez
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

3.  Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma.

Authors:  Huizhen Nie; Qingzhen Cao; Lei Zhu; Yuehua Gong; Jianren Gu; Zuping He
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models.

Authors:  Kenza Mamouni; Shumin Zhang; Xin Li; Yanhua Chen; Yang Yang; Jaeah Kim; Michael G Bartlett; Ilsa M Coleman; Peter S Nelson; Omer Kucuk; Daqing Wu
Journal:  Neoplasia       Date:  2018-07-04       Impact factor: 5.715

5.  Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer.

Authors:  Daksh Thaper; Sepideh Vahid; Ramandeep Kaur; Sahil Kumar; Shaghayegh Nouruzi; Jennifer L Bishop; Martin Johansson; Amina Zoubeidi
Journal:  Sci Rep       Date:  2018-11-23       Impact factor: 4.379

6.  Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer.

Authors:  L Tam; L M McGlynn; P Traynor; R Mukherjee; J M S Bartlett; J Edwards
Journal:  Br J Cancer       Date:  2007-06-26       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.